ProQR Therapeutics N.V (PRQR) up 104.55% since start of the year

ProQR Therapeutics N.V (NASDAQ: PRQR) is 104.55% higher on its value in year-to-date trading and has touched a low of $1.11 and a high of $4.62 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRQR stock was last observed hovering at around $4.33 in the last trading session, with the day’s loss setting it -0.28%.

Currently trading at $4.05, the stock is 75.14% and 92.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.19 million and changing -6.47% at the moment leaves the stock 100.47% off its SMA200. PRQR registered 200.00% gain for a year compared to 6-month loss of 102.50%. The firm has a 50-day simple moving average (SMA 50) of $2.0991 and a 200-day simple moving average (SMA200) of $2.020225.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 134.10% gain in the last 1 month and extending the period to 3 months gives it a 114.85%, and is 123.76% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 34.55% over the week and 14.30% over the month.

Profit margin for the company is -140.14%. Distance from 52-week low is 264.86% and -12.34% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.37%).

with sales reaching $12.04M over the same period.The EPS is expected to grow by 3.13% this year, but quarterly earnings will post 175.50% year-over-year. Quarterly sales are estimated to grow 709.10% in year-over-year returns.

ProQR Therapeutics N.V (PRQR) Top Institutional Holders

The shares outstanding are 78.46M, and float is at 52.75M with Short Float at 0.28%.

The top institutional shareholder in the company is PRIVIUM FUND MANAGEMENT B.V. with over 5.58 million shares valued at $9.21 million. The investor’s holdings represent 6.8416% of the PRQR Shares outstanding. As of 2024-06-30, the second largest holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with 3.63 million shares valued at $6.02 million to account for 4.4446 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 2.04 million shares representing 2.5043% and valued at over $3.39 million, while M28 CAPITAL MANAGEMENT LP holds 1.2498 of the shares totaling 1.02 million with a market value of $1.69 million.